Forre O T, Johnson P M, Natvig J B
Scand J Rheumatol. 1977;6(2):113-7. doi: 10.3109/03009747709095432.
Ten IgM polyclonal rheumatoid factor (RF) preparations isolated from sera from various patients with rheumatoid arthritis (RA) were investigated with respect to their variable heavy chain (VH) subgroups. They were tested in a haemagglutination inhibition system using red cells sensitized with myeloma proteins with known chemical VH subgroups and anti-VH subgroup specific antisera. Most of the preparations showed a considerable degree of restriction to one VH subgroup. Seven of the IgM-RF preparations were restricted to the VHIII subgroup, two to the VHI subgroup and one to the VHII subgroup. However, a weak reaction in other VH subgroup systems was seen in several instances. Two normal IgM fractions from healthy persons showed no VH subgroup restriction, and showed a rather similar degree of reaction in all the three subgroup systems.
对从不同类风湿性关节炎(RA)患者血清中分离出的10种IgM多克隆类风湿因子(RF)制剂进行了可变重链(VH)亚组研究。在血凝抑制系统中,使用已知化学VH亚组的骨髓瘤蛋白致敏红细胞和抗VH亚组特异性抗血清对它们进行检测。大多数制剂对一个VH亚组表现出相当程度的限制。7种IgM-RF制剂局限于VHIII亚组,2种局限于VHI亚组,1种局限于VHII亚组。然而,在一些情况下,在其他VH亚组系统中观察到微弱反应。来自健康人的两种正常IgM组分未表现出VH亚组限制,并且在所有三个亚组系统中的反应程度相当相似。